© 2022 MJH Life Sciences and CURE - Oncology & Cancer News for Patients & Caregivers. All rights reserved.
© 2022 MJH Life Sciences™ and CURE - Oncology & Cancer News for Patients & Caregivers. All rights reserved.
Expert oncologist Julie Fisher, MD, is joined by her patient Jocelyn Mueller, who shares her personal journey with HER2-positive breast cancer.
October 22nd 2021
Julie Fisher, MD, gives a brief overview of HER2-positive breast cancer and the tests available for diagnosis.
Jocelyn Mueller, a patient with HER2-positive breast cancer, explains how she received her diagnosis.
October 29th 2021
Dr. Julie Fisher, an expert oncologist, describes the range of treatment options for HER2-positive breast cancer in the pre-operative setting.
Dr. Julie Fisher details the therapies used for HER2-positive breast cancer in the post-operative setting, including newly available treatment options, and reviews data supporting the choice of therapy for each patient.
November 5th 2021
Jocelyn Mueller describes the preoperative treatments she has received for HER2-positive breast cancer, and the questions she had for her medical care team.
Julie Fisher, MD, explains how she assesses HER2-positive breast cancer patients for treatment response, what side-effects can occur and how they can be managed.
November 12th 2021
Jocelyn Mueller details how chemotherapy treatments have affected her daily life and her decision to receive treatment through a port.
Julie Fisher, M.D., has a conversation with patient Jocelyn Mueller about the importance of good support networks when living with HER2-positive breast cancer.
November 19th 2021
Patient Jocelyn Mueller and oncologist Julia Fisher, M.D., describe some of the adjustments that had to be made to Jocelyn’s treatment for HER2-positive breast cancer due to the COVID-19 pandemic.
March 17th 2022
Jocelyn Mueller, a patient with HER2-postive breast cancer, explains the recovery process after surgery and the impact that the availability sub-cutaneous HER2-targeting therapy has had on her breast cancer journey.
Jocelyn Mueller describes the treatment process with sub-cutaneous HER2-targeting therapy post-operatively and some of the adjustments that she made to her daily life.
March 24th 2022
Jocelyn Mueller details her experience with her caregiver and the describes the support she received from her community as she continues her journey.
Sophie Mueller, Jocelyn’s daughter and caregiver, explains her perspectives as a caregiver to Jocelyn and how that impacted her life.
April 4th 2022
Sophie Mueller provides advice for patients and caregivers with breast cancer who may be in similar situations.
Years After My Diagnosis, I Still Can’t Shake the Cancer Hound That Chases Me
A ‘Lighthouse Through the Cancer Storm’
Cancer Creates Empathy, But Hope Must Prevail
Creating an Extraordinary Environment for Cancer Healing